SCHEMBL25840843

SCHEMBL25840843

Cc1ccc(NC(=S)NCC(=O)OC(C)(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
GAA P10253 3/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MAPKAPK2 P49137 2/20 0.47
MAPT P10636 2/20 0.47
MAPK1 P28482 1/20 0.47
ABAT P80404 1/20 0.46
MEN1 O00255 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
RAB9A P51151 1/20 0.44
CCR6 P51684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1258488 0.87 ABAT (0.64) SMN1; SMN2GAANPSR1ABATMEN1
SCHEMBL25840841 0.85 NPC1 (0.55) SMN1; SMN2TDP1MAPTMEN1CYP1A2
SCHEMBL23328386 0.85 CDK1 (0.56) SMN1; SMN2GAAMAPTABATMEN1
SCHEMBL10453740 0.83 IDO1 (0.49) GAAMAPKAPK2MAPTMAPK1ABAT
SCHEMBL25840794 0.80 ABAT (0.72) SMN1; SMN2GAAMAPTABATMEN1
SCHEMBL1039226 0.80 MAPT (0.47) GAANPSR1TDP1MAPTMEN1
SCHEMBL21319443 0.76 SMN1; SMN2 (0.66) SMN1; SMN2GAANPSR1TDP1MAPT
SCHEMBL12301492 0.75 TDP1 (0.65) SMN1; SMN2GAATDP1MAPTMEN1
SCHEMBL14679376 0.75 POLB (0.54) SMN1; SMN2NPSR1MAPTMEN1HTT
SCHEMBL3975014 0.75 MAPKAPK2 (0.57) SMN1; SMN2GAAMAPKAPK2MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 SMN1; SMN2 3087/4885GAA 1854/4885NPSR1 2291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.